H.I.G. Capital, a global alternative investment firm, completed the acquisition of the spine business of ZimVie, a global life sciences firm, for $375m. "The ZimVie spine business has a solid foundation with a market-leading product portfolio, strong surgeon satisfaction and exceptional patient outcomes. We see a tremendous opportunity to partner with the spine leadership team to support best-in-class innovation and robust commercial execution. The combination of H.I.G.’s expertise in the medical device space and the capabilities of ZimVie spine management will create an innovation engine for distributors, surgeons and patients," Mike Gallagher, H.I.G. Capital Managing Director.